scholarly journals 65 Ruptured abdominal aortic aneurysms with aorto-vena cava or iliac vein fistula

1985 ◽  
Vol 15 (1) ◽  
pp. 91-92 ◽  
Author(s):  
T. Ikezawa
1997 ◽  
Vol 12 (3) ◽  
pp. 112-114
Author(s):  
J. I. Martínez-León ◽  
J. C. Bohórquez-Sierra ◽  
A. R. Sánchez-Guzmán ◽  
F. N. Arribas-Aguilar ◽  
F. Ceijas-Lloreda ◽  
...  

Objective: To report two cases of inferior vena cava (IVC) and iliac vein thrombosis secondary to expansive and ruptured abdominal aortic aneurysms. Design: Case report. Setting: Angiology and Vascular Surgery Unit, Hospital Universitario Puerta del Mar, Cádiz, Spain. Patients: Patients with clinical and radiological evidence of IVC and iliac vein thrombosis secondary to a sealed rupture from expanding aortic aneurysms. Interventions: Surgical repair in one case and conservative management in the second case. Conclusions: Venous compression was relieved, avoiding the risk associated with anticoagulant therapy in the presence of an aortic aneurysm. Ultrasound scanning is useful in assessing deep venous thrombosis and detecting compressive masses such as aortic and iliac aneurysms. Inappropriate management of patients with venous obstruction from undiagnosed arterial aneurysms may cause serious complications.


2008 ◽  
Vol 136 (Suppl. 3) ◽  
pp. 199-203 ◽  
Author(s):  
Igor Koncar ◽  
Nebojsa Savic

INTRODUCTION. Recombinant form of activated factor VII (rFVIIa) has been approved for use in haemophiliacs with antibodies to factor VIII or factor IX. Recent studies and clinical experiences have showed that rFVIIa gives extreme haemostatic effects in patients with severe ?nonhaemophilic? bleeding produced after trauma and major surgery. OBJECTIVE. We present our preliminary experience of the use of rFVIIa in vascular surgery where conventional haemostatic measures were inadequate. METHOD. There were 17 patients divided into three groups: Group I - 6 patients with ruptured abdominal aortic aneurysms; Group II - 7 patients with thoracoabdominal aortic aneurysms and 1 patient with acute complicated dissection of thoracic aorta type III; Group III - 3 patients with retroperitoneal tumours involving great abdominal vessels. RESULTS. Clinical improvement was reported following the treatment in 14 of 17 patients in our study. Bleeding was successfully controlled as evidenced by improved haemodynamic parameters and decreased inotrope and transfusion requirement. CONCLUSION. More liberal use of rFVIIa in vascular patients is limited, because there is no randomized controlled trial proving efficacy and safety in vascular patients. We recommend the use of rFVIIa in vascular surgery only during and after operative treatment of thoracoabdominal aortic aneurysms, ruptured abdominal aortic aneurysms and retroperitoneal tumours involving aorta and/or inferior vena cava complicated with ?non-surgical? massive uncontrolled bleeding.


2001 ◽  
Vol 71 (6) ◽  
pp. 341-344
Author(s):  
Johanna Rose ◽  
Ian Civil ◽  
Timothy Koelmeyer ◽  
David Haydock ◽  
Dave Adams

VASA ◽  
2019 ◽  
Vol 48 (1) ◽  
pp. 35-46
Author(s):  
Stephen Hofmeister ◽  
Matthew B. Thomas ◽  
Joseph Paulisin ◽  
Nicolas J. Mouawad

Abstract. The management of vascular emergencies is dependent on rapid identification and confirmation of the diagnosis with concurrent patient stabilization prior to immediate transfer to the operating suite. A variety of technological advances in diagnostic imaging as well as the advent of minimally invasive endovascular interventions have shifted the contemporary treatment algorithms of such pathologies. This review provides a comprehensive discussion on the current state and future trends in the management of ruptured abdominal aortic aneurysms as well as acute aortic dissections.


Sign in / Sign up

Export Citation Format

Share Document